Merck to licence two preclinical immuno oncology programs from F-star
Two additional preclinical discovery programs will be added to the Merck KGaA and F-star Therapeutics collaboration. Merck KGaA, Darmstadt, Germany
Read more
Preclinical Studies
BioMed Raises $177M to Accelerate Next-Gen Biologics Development
Harbour BioMed, a global clinical stage biopharmaceutical company developing novel therapeutics in the fields of immuno-oncology, immunologic diseases, and COVID-19,
Read more
New high CBD cannabis sativa could be effective against SARS-CoV2
Recent Canada-based research studies on cannabis sativa extract with high CBD content are demonstrating encouraging outcomes, such as inhibiting the
Read more
AbbVie and BioMed to develop monoclonal antibody for COVID-19
AbbVie, Harbour BioMed, Utrecht University and the Erasmus Medical Center (EMC) revealed today they have entered into a partnership to
Read more
Preventative approaches and treatment options for COVID-19
Researchers across the world are racing to develop preventative approaches and treatment options for COVID-19, including monoclonal antibodies, vaccines and
Read more
Vault Pharma designing new Vault-based Coronavirus Vaccine
Vault Pharma is collaborating with UCLA and other universities to develop a coronavirus vaccine with the capacity to treat the
Read more
BioMed, Utrecht University and Erasmus discover antibody blocking SARS-CoV-2 in cells
Scientists at clinical-stage biopharmaceutical company Harbour BioMed (HBM), Utrecht University and Erasmus Medical Center announced that they have discovered a
Read more
ARTES joins fight against COVID-19 with VLP vaccine platforms
ARTES Biotechnology, a Germany-based biotechnology company specialising in process development for recombinant vaccines, has commenced the development of SARS-CoV-2 vaccine
Read more
BioNTech and Pfizer to start first COVID-19 vaccine human trial in Germany
German biotechnology company BioNTech is collaborating with Pfizer to develop the BNT162 vaccine programme to prevent COVID-19. The Mainz-based company
Read more
Vaxart shows positive pre-clinical data for oral COVID-19 vaccine
Vaxart, a clinical-stage biotechnology organisation developing oral recombinant vaccines delivered via tablet rather than an injection, reported on April 21
Read more